Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease

Dermato-Endocrinology

Volumn 3, Issue 2, 2011, Pages 77-83

  Radner, Franz P W ^a   Grond, Susanne ^a   Haemmerle, Guenter ^a   Lass, Achim ^a   Zechner, Rudolf ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

ABHD5; ATGL; Ceramide; CGI 58; Ichthyosis; Keratinocyte; Lipids; Triacylglycerol

Indexed keywords

ACYL COENZYME A; ACYL[ACYL CARRIER PROTEIN] PHOSPHOLIPID ACYLTRANSFERASE; ACYLTRANSFERASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; DISEASE COURSE; EXON; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; HUMAN; ICHTHYOSIS; INTRON; KERATINOCYTE; LIPID HYDROLYSIS; LIPID METABOLISM; LIPIDOSIS; MISSENSE MUTATION; MYOPATHY; NONHUMAN; NONSENSE MUTATION; PERMEABILITY BARRIER; REVIEW; SKIN PERMEABILITY;

EID: 79956106129     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.3.2.15472     Document Type: Review

References (99)

1. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31:5-19. (Pubitemid 29164098)
2. Kalinin AE, Kajava AV, Steinert PM. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002; 24:789-800. (Pubitemid 35022184)
3. Madison KC. Barrier function of the skin: "la raison d'etre" of the epidermis. J Invest Dermatol 2003; 121:231-41.
4. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17:1063-72.
5. Jensen JM, Proksch E. The skin's barrier. G Ital Dermatol Venereol 2009; 144:689-700.
6. Wertz PW. Epidermal lipids. Semin Dermatol 1992; 11:106-13.
7. Wertz PW. Biochemistry of human stratum corneum lipids. In: Elias PM, Feingold KR, ed(s). Skin Barrier. New York, NY: Taylor & Francis Group 2006; 33-42.
8. Feingold KR. The outer frontier: the importance of lipid metabolism in the skin. J Lipid Res 2009; 50:417-22.
9. Wertz PW, Downing DT, Freinkel RK, Traczyk TN. Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol 1984; 83:193-5. (Pubitemid 14063907)
10. Freinkel RK, Traczyk TN. Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J Invest Dermatol 1985; 85:295-8. (Pubitemid 15248011)
11. Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM. Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 1985; 85:289-94. (Pubitemid 15248010)
12. Schmitz G, Muller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991; 32:1539-70.
13. Elias PM, Feingold KR, Fartasch M. Epidermal lamellar body as a multifunctional secretory organelle. In: Elias PM, Feingold KR, Ed(s). Skin Barrier. New York, NY: Taylor & Francis Group 2006; 261-72.
14. Rozenszajn L, Klajman A, Yaffe D, Efrati P. Jordans' anomaly in white blood cells. Report of case. Blood 1966; 28:258-65.
15. Dorfman ML, Hershko C, Eisenberg S, Sagher F. Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol 1974; 110:261-6.
16. Chanarin I, Patel A, Slavin G, Wills EJ, Andrews TM, Stewart G. Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J 1975; 1:553-5.
17. Jordans GH. The familial occurrence of fat containing vacuoles in the leukocytes diagnosed in two brothers suffering from dystrophia musculorum progressiva (ERB). Acta Med Scand 1953; 145:419-23.
18. Igal RA, Rhoads JM, Coleman RA. Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr 1997; 25:541-7. (Pubitemid 27463293)
19. Schweiger M, Lass A, Zimmermann R, Eichmann TO, Zechner R. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab 2009; 297:289-96.
20. Williams ML, Monger DJ, Rutherford SL, Hincenbergs M, Rehfeld SJ, Grunfeld C. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts. J Inherit Metab Dis 1988; 11:131-43.
21. Williams ML, Coleman RA, Placezk D, Grunfeld C. Neutral lipid storage disease: a possible functional defect in phospholipid-linked triacylglycerol metabolism. Biochim Biophys Acta 1991; 1096:162-9.
22. Salvayre R, Negre A, Radom J, Douste-Blazy L. Independence of triacylglycerol-containing compartments in cultured fibroblasts from Wolman disease and multisystemic lipid storage myopathy. FEBS Lett 1989; 250:35-9. (Pubitemid 19154175)
23. Radom J, Salvayre R, Negre A, Maret A, Douste-Blazy L. Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy. Eur J Biochem 1987; 164:703-8. (Pubitemid 17072827)
24. Radom J, Salvayre R, Maret A, Negre A, Douste-Blazy L. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy. Biochim Biophys Acta 1987; 920:131-9. (Pubitemid 17100935)
25. Radom J, Salvayre R, Levade T, Douste-Blazy L. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus- transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects. Biochem J 1990; 269:107-13. (Pubitemid 20210847)
26. Hilaire N, Salvayre R, Thiers JC, Bonnafe MJ, Negre-Salvayre A. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways. J Biol Chem 1995; 270:27027-34.
27. Igal RA, Coleman RA. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem 1996; 271:16644-51. (Pubitemid 26239023)
28. Igal RA, Coleman RA. Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism. J Lipid Res 1998; 39:31-43. (Pubitemid 28063540)
29. Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/ thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 2001; 69:1002-12. (Pubitemid 33015815)
30. Akiyama M, Sawamura D, Nomura Y, Sugawara M, Shimizu H. Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome. J Invest Dermatol 2003; 121:1029-34. (Pubitemid 37430969)
31. Srinivasan R, Hadzic N, Fischer J, Knisely AS. Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation. J Pediatr 2004; 144:662-5. (Pubitemid 38594772)
32. Pujol RM, Gilaberte M, Toll A, Florensa L, Lloreta J, Gonzalez-Ensenat MA, et al. Erythrokeratoderma variabilis-like ichthyosis in Chanarin-Dorfman syndrome. Br J Dermatol 2005; 153:838-41. (Pubitemid 41415917)
33. Schleinitz N, Fischer J, Sanchez A, Veit V, Harle JR, Pelissier JF. Two new mutations of the ABHD5 gene in a new adult case of Chanarin Dorfman syndrome: an uncommon lipid storage disease. Arch Dermatol 2005; 141:798-800. (Pubitemid 41001097)
34. Lass A, Zimmermann R, Haemmerle G, Riederer M, Schoiswohl G, Schweiger M, et al. Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006; 3:309-19.
35. Ben Selma Z, Yilmaz S, Schischmanoff PO, Blom A, Ozogul C, Laroche L, et al. A novel S115G mutation of CGI-58 in a Turkish patient with Dorfman-Chanarin syndrome. J Invest Dermatol 2007; 127:2273-6. (Pubitemid 47258497)
36. Bruno C, Bertini E, Di Rocco M, Cassandrini D, Ruffa G, De Toni T, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome. Biochem Biophys Res Commun 2008; 369:1125-8.
37. Badeloe S, van Geel M, Nagtzaam I, Rubio-Gozalbo ME, Oei RL, Steijlen PM, et al. Chanarin-Dorfman syndrome caused by a novel splice site mutation in ABHD5. Br J Dermatol 2008; 158:1378-80. (Pubitemid 351692872)
38. Ronchetti A, Prati D, Pezzotta MG, Tavian D, Colombo R, Callea F, et al. Severe steatohepatitis in a patient with a rare neutral lipid storage disorder due to ABHD5 mutation. J Hepatol 2008; 49:474-7.
39. Ujihara M, Nakajima K, Yamamoto M, Teraishi M, Uchida Y, Akiyama M, et al. Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman-Chanarin syndrome. J Dermatol Sci 2010; 57:102-7.
40. Emre S, Unver N, Evans SE, Yuzbasioglu A, Gurakan F, Gumruk F, et al. Molecular analysis of Chanarin- Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 gene. Eur J Med Genet 2010; 53:141-4.
41. Cakir M, Bruno C, Cansu A, Cobanoglu U, Erduran E. Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5. Acta Paediatr 2010; 99:1592-4.
42. Redaelli C, Coleman RA, Moro L, Sertedaki A, Kakourou T, Elsayed SM, et al. Clinical and genetic characterization of Chanarin-Dorfman Syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis 2010; 5:33.
43. Williams ML. Ichthyosis: mechanisms of disease. Pediatr Dermatol 1992; 9:365-8. (Pubitemid 23004687)
44. Demerjian M, Crumrine DA, Milstone LM, Williams ML, Elias PM. Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome). J Invest Dermatol 2006; 126:2032-8.
45. Lai CH, Chou CY, Ch'ang LY, Liu CS, Lin W. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res 2000; 10:703-13.
46. Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S, et al. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem 2004; 279:42062-71. (Pubitemid 39313657)
47. Yamaguchi T, Omatsu N, Morimoto E, Nakashima H, Ueno K, Tanaka T, et al. CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J Lipid Res 2007; 48:1078-89. (Pubitemid 46708675)
48. Watt MJ, Steinberg GR. Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J 2008; 414:313-25.
49. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A. Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009; 50:3-21.
50. Zimmermann R, Lass A, Haemmerle G, Zechner R. Fate of fat: the role of adipose triglyceride lipase in lipolysis. Biochim Biophys Acta 2009; 1791:494-500.
51. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50:14-27.
52. Yamaguchi T, Omatsu N, Matsushita S, Osumi T. CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J Biol Chem 2004; 279:30490-7. (Pubitemid 38937979)
53. Fischer J, Lefevre C, Morava E, Mussini JM, Laforet P, Negre-Salvayre A, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007; 39:28-30. (Pubitemid 46026498)
54. Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H. Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve 2007; 36:856-9. (Pubitemid 350246936)
55. Kobayashi K, Inoguchi T, Maeda Y, Nakashima N, Kuwano A, Eto E, et al. The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets. J Clin Endocrinol Metab 2008; 93:2877-84. (Pubitemid 352008564)
56. Ohkuma A, Nonaka I, Malicdan MC, Noguchi S, Ohji S, Nomura K, et al. Distal lipid storage myopathy due to PNPLA2 mutation. Neuromuscul Disord 2008; 18:671-4.
57. Campagna F, Nanni L, Quagliarini F, Pennisi E, Michailidis C, Pierelli F, et al. Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy. Biochem Biophys Res Commun 2008; 377:843-6.
58. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G. Triglyceride deposit cardiomyovasculopathy. N Engl J Med 2008; 359:2396-8.
59. Akman HO, Davidzon G, Tanji K, Macdermott EJ, Larsen L, Davidson MM, et al. Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul Disord 2010; 20:397-402.
60. Chen J, Hong D, Wang Z, Yuan Y. A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles. Clin Neuropathol 2010; 29:351-6.
61. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312:734-7.
62. Radner FP, Streith IE, Schoiswohl G, Schweiger M, Kumari M, Eichmann TO, et al. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 2010; 285:7300-11.
63. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000; 114:185-92. (Pubitemid 30195993)
64. Stewart ME, Downing DT. The omega-hydroxyceramides of pig epidermis are attached to corneocytes solely through omega-hydroxyl groups. J Lipid Res 2001; 42:1105-10. (Pubitemid 32645792)
65. Uchida Y, Holleran WM. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 2008; 51:77-87.
66. Wertz PW, Downing DT. Metabolism of linoleic acid in porcine epidermis. J Lipid Res 1990; 31:1839-44. (Pubitemid 20387352)
67. Akiyama M, Sakai K, Takayama C, Yanagi T, Yamanaka Y, McMillan JR, et al. CGI-58 is an alpha/betahydrolase within lipid transporting lamellar granules of differentiated keratinocytes. Am J Pathol 2008; 173:1349-60.
68. Menon GK, Grayson S, Elias PM. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol 1986; 86:591-7. (Pubitemid 16052566)
69. Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993; 91:1656-64. (Pubitemid 23127370)
70. Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, et al. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994; 93:1756-64.
71. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, et al. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res 1994; 35:905-12. (Pubitemid 24157241)
72. Jensen JM, Schutze S, Forl M, Kronke M, Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999; 104:1761-70. (Pubitemid 30053193)
73. Schmuth M, Man MQ, Weber F, Gao W, Feingold KR, Fritsch P, et al. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000; 115:459-66.
74. Mao-Qiang M, Feingold KR, Jain M, Elias PM. Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 1995; 36:1925-35.
75. Mao-Qiang M, Jain M, Feingold KR, Elias PM. Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol 1996; 106:57-63.
76. Wertz PW. Lipids and barrier function of the skin. Acta Derm Venereol Suppl 2000; 208:7-11.
77. Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007; 48:2531-46. (Pubitemid 350272838)
78. Elias PM, Williams ML. Neutral lipid storage disease with ichthyosis. Defective lamellar body contents and intracellular dispersion. Arch Dermatol 1985; 121:1000-8.
79. Uchida Y, Cho Y, Moradian S, Kim J, Nakajima K, Crumrine D, et al. Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. J Invest Dermatol 2010; 130:2497-9.
80. Toulza E, Mattiuzzo NR, Galliano MF, Jonca N, Dossat C, Jacob D, et al. Large-scale identification of human genes implicated in epidermal barrier function. Genome Biol 2007; 8:107.
81. Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold KR, Elias PM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004; 279:11767-76. (Pubitemid 38401682)
82. Ghosh AK, Ramakrishnan G, Chandramohan C, Rajasekharan R. CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid. J Biol Chem 2008; 283:24525-33.
83. Montero-Moran G, Caviglia JM, McMahon D, Rothenberg A, Subramanian V, Xu Z, et al. CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase. J Lipid Res 2010; Apr;51:709-19.
84. Gruber A, Cornaciu I, Lass A, Schweiger M, Poeschl M, Eder C, et al. The N-terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase. J Biol Chem 2010; 285:12289-98.
85. Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 2001; 27:121-4. (Pubitemid 32044532)
86. 2+-dependent phosphatidate phosphatase enzyme. J Biol Chem 2006; 281:9210-8.
87. Mauro T, Holleran WM, Grayson S, Gao WN, Man MQ, Kriehuber E, et al. Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290:215-22. (Pubitemid 28230774)
88. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117:44-51. (Pubitemid 32652438)
89. Takagi Y, Nakagawa H, Matsuo N, Nomura T, Takizawa M, Imokawa G. Biosynthesis of acylceramide in murine epidermis: characterization by inhibition of glucosylation and deglucosylation and by substrate specificity. J Invest Dermatol 2004; 122:722-9. (Pubitemid 38471342)
90. Reichert U, Michel S, Schmidt R. The cornified envelope: a key structure of terminally differentiating keratinocytes. In: Darmon M, Blumenberg M, eds. Molecular Biology of the Skin: the Keratinocyte. San Diego, CA: Academic Press, Inc., 1993:107-50.
91. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6:328-40. (Pubitemid 40516899)
92. Reichrath J, Mittmann M, Kamradt J, Muller SM. Expression of retinoid-X receptors (-alpha, -beta, -gamma) and retinoic acid receptors (-alpha, -beta, -gamma) in normal human skin: an immunohistological evaluation. Histochem J 1997; 29:127-33. (Pubitemid 27192187)
93. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998; 111:1116-21. (Pubitemid 29115184)
94. Russell LE, Harrison WJ, Bahta AW, Zouboulis CC, Burrin JM, Philpott MP. Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp Dermatol 2007; 16:844-52. (Pubitemid 47377650)
95. Schmuth M, Jiang YJ, Dubrac S, Elias PM, Feingold KR. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008; 49:499-509.
96. Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD, et al. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol 1998; 110:368-75. (Pubitemid 28158652)
97. Hanley K, Ng DC, He SS, Lau P, Min K, Elias PM, et al. Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol 2000; 114:545-53. (Pubitemid 30415343)
98. Gao J, Simon M. Identification of a novel keratinocyte retinyl ester hydrolase as a transacylase and lipase. J Invest Dermatol 2005; 124:1259-66. (Pubitemid 40847414)
99. Gao JG, Simon M. A comparative study of human GS2, its paralogues and its rat orthologue. Biochem Biophys Res Commun 2007; 360:501-6. (Pubitemid 47030372)